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Background: As a direct result of the population growing older the total number of chronic illnesses increases.
The future expenditure for care of chronically ill patients is an ever-present challenge for the health care system.
New solutions based on integrated care or the inclusion of telemedical systems in the treatment procedure can
be essential for reducing the future financial burden. Therefore a detailed economic model was developed, which
enables the comparison of health and cost outcomes for conventional medical care and different integrated care
concepts in heart failure treatment.
Methods: For modelling, the discrete event technique was used. The model takes outpatient care as well as
inpatient care into account to estimate the total occurring costs. It enables the treatment of patients by a physician,
a specialist or a clinical ambulance for the simulation of the outpatient care. For inpatient care the model considers
the total-costs of the hospitalization and rate of re-admission and furthermore the costs which occur because of
special medical treatments or necessary stay at intensive care units. To rate the severity of symptoms patients can
be classified using NYHA groups. To outline some of the potential model results, two scenarios have been
simulated to compare both methods of care regarding overall costs.
Results: The developed simulation model allows comparing health and cost outcomes of different integrated
care concepts for the treatment of heart failure patients. Additionally to the simulation of standard outpatient
and inpatient care procedures in Austria the approach of a telemedical monitoring system for heart failure patients
was implemented in this economic model. With the simulated scenarios it could be shown that under the given
simulation parameters the telemedical system can lead to cost savings of up to 8% within the first three years.
Conclusions: The developed model represents a comprehensive tool, which opens a wide field of possible
simulation scenarios for the treatment of heart failure patients with special focus on overall cost estimations and
reimbursement strategies. The simulated scenarios show that telemedical care has the potential of improved health
outcomes and economic benefits.
Keywords: Decision-analytic model; Discrete event simulation; Economic evaluation; Conventional care;
Telemonitoring; Cost estimation; Cost-effectiveness analysesBackground
The demographic development resulting from the so
called “double aging” effect shows that the population
distribution has already changed considerably and will
further change over the next decades. The proportion
of people above the age of 60 increases dramatically.
Estimations indicate that in about 20 years every forth
will be above 60 and every ninth above 75 years. This* Correspondence: schroettner@tugraz.at
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2013expected increase of older people in society poses an
immense challenge to the public health care system, since
the consequential rise of chronic illnesses represents a not
to be underestimated burden [1,2]. About 70% of the
population between 70 and 79 years will suffer at least
from one of the five most widespread chronic diseases
such as heart failure (HF), which numbers among the
most internistic illnesses. About 1-2% of people in the
United States and in Western Europe are estimated to
live with heart failure and prevalence increases because
of the aging of population [3-5]. At the age of 45 toger. This is an open access article distributed under the terms of the Creative
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failure, between 65 and 75 years this value varies from
2 to 5% and rises to about 10% at the age of 80 years
and above [6-8]. As a logical consequence expenses for
the treatment of these patients will increase noticeably.
Health expenditures on chronic heart failure are estimated
to account for 1-2% of the total health care budget of
western industrialized countries and almost two-thirds
of them is due to hospitalizations [9]. Moreover epi-
demiological data shows that heart failure is the leading
cause for hospitalizations regarding patients older than
65 years [6]. It is clear that new strategies for patient
management or new methods of medical care such as
the possibility of telemedical treatment can be essential
for the reduction of the future financial burden. The
advantage of telemedical treatment of heart failure
patients lies within the earlier detection of symptoms
and abnormal vital parameters compared to standard
care solutions. Thus treatment at an early stage is possible
whereby the health status can be rather stabilized and
frequent doctor visits and/or hospitalizations can be
reduced and/or prevented [10]. These propositions are
supported through the results of many publications and
reviews concerning patient outcomes and economic
impact of telemedical treatment programs. For example
Seto in 2008 performed a systematic review regarding
cost comparison between telemonitoring and usual care
of heart failure. It was concluded that costs can be
reduced between 1.6 to 68.3% by using a telemonitoring
system including a component of home physiological
measurements. Although telemonitoring systems require
an initial investment, they substantially reduce costs in
the long term [11]. Klersy et al. in 2011 investigated the
economic impact of remote patient monitoring. A cost
simulation model was constructed to compare this
strategy with usual care. Results show that direct costs
for hospitalization are lower for telemonitoring systems
with a range from 300 to 1000 Euro per patient. It was
concluded that the overall acceptance of remote patient
monitoring was encouraged, but there is still a lack of
prospectively and uniformly collected economic data
[12]. A comprehensive tool such as a model for simulation
of different treatment procedures of heart failure patients
would provide a lot of possibilities for prospective cost
estimations. On this basis the aim of this work is to
present a detailed heart failure model with the ability to
compare the incurred costs of conventional medical
care and different integrated care approaches including
telemonitoring of heart failure patients.
Methods
The model was implemented using the simulation soft-
ware AnylogicTMW (XJ Technologies, Russian Federation),
applying the discrete event modelling technique. Thismethod has a middle to low degree of abstraction and
allows the description of event based procedures by the
implementation of objects and resources.
The treatment procedures of telemedical and conven-
tional care are not identical, thus two separate versions
of the model have been created. Each version contains
four modules, whereas the patients are treated in one of
the four implemented NYHA classes (New York Heart
Association) [13]. Depending on the NYHA class of the
patient, the implemented probabilities for decisions
regarding different events in the model change. The
more severe the heart failure is, the higher the chances
for negative events are. As an example NYHA 3 patients
are more likely to be hospitalized, have on average a
higher length of stay and are more likely to face individual
medical procedures (IMP) than NYHA 2 patients.
Additionally every module consists of 2 blocks whereby
the first one represents the patient’s treatment outside
the hospital (outpatient care) and the second one refers
to the stationary treatment process (inpatient care). All
differences, based on the use of a telemonitoring system
instead of conventional patient care, solely concern the
outpatient care. The implementation of the inpatient care
process is equal for both versions of the model. Of course
different outcomes, such as length of hospital stay or
necessary individual medical procedures are modifiable
in both model versions. Figure 1 shows a simple overview
of the model and outlines the most important influence
parameters and resources which were considered to model
the outpatient and inpatient care of heart failure patients.
As a main parameter of the general model structure,
the NYHA class indicates the severity of heart failure
and thus affects for example probabilities for mortalities,
admissions to the hospital, intensive care stays and
emergency transports. The treatment resources of the
outpatient care are the general practitioner, the specialist,
the ambulance unit and emergency events. Based on
implemented probabilities, these decision items influence
the further treatment procedures.
For the inpatient care, patients have different lengths of
stay depending on the severity of heart failure and can face
admissions to intensive care units and individual medical
procedures. The potential improvement or deterioration of
the patients’ state of health is reflected by NYHA class
changes after the in-hospital stay. As shown in Figure 1,
both concepts of care consider implemented morality rates.
Since a model is always an approximation of the real
world, the quality of implemented data is important to
achieve reliable results. As a data source, the MOBITEL
study [14] delivered insights on the effects of the teleme-
dical treatment compared to the conventional approach.
Rates of admission (standard and intensive), length of stay,
medication and mortality rates could be adopted for the
simulated scenarios. Cost estimations for outpatient
Figure 1 Model overview and influence parameters for the outpatient and inpatient care of heart failure patients.
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for inpatient care on the Austrian DRG system [15].
The model also considers health outcomes of patients
undergoing conventional or telemedical treatment. For
example the NYHA progression over time, the amount of
hospital admissions and mortality rates are integrated
in the model.
The validation of the model was performed using the
“V-model” development process [16]. In the verification
phase it was proven that implementations in each module
represent the predefined specifications. The validation
process of determining to which degree the functional
specifications of the model are fulfilled was based
on simulated scenarios with regard to results of the
MOBITEL study [14].
Inpatient care
Principally there are three events implemented in the
simulation models which can lead to a hospitalization of
the patient: Any emergency, if interventions implicate
no improvement of the patient’s health status or if the
treating physician recommends the admission to the
hospital. For in-hospital treatment the model distinguishes
between inpatient and intensive care admissions. De-
pending on the severity of the patient’s health status, an
intensive care treatment can be necessary. The whole
procedure of inpatient care is illustrated in Figure 2.
In both, standard and intensive care individual med-
ical procedures based on the Austrian diagnoses related
groups (DRG) system can be passed through by individual
patients. The expenses of each individual medical proced-
ure are considered in the model. Detailed information on
cost estimation is given at the end of the methods section.
As you can see in Figure 2 the inpatient care procedures
allow the patients to change from standard hospital
treatment to intensive care treatment and vice-versa.
The patient leaves the hospital if the physical health
status improves. This is implemented in the simulation
model by the allocation of a specific length of stay in thehospital. After the hospital discharge and a potential
change of the NYHA class the patient leaves block 2
and is redirected to block 1, the outpatient care. If no
improvement of the patient’s health status takes place,
mortality rates are implemented in the inpatient care
treatment. Patient death leads to the removal from the
simulation.Outpatient care – procedure of conventional treatment
The outpatient conventional care treatment is illustrated
in Figure 3. A worsening of the patient’s health condition,
which is reflected by implemented probabilities with
regard to the severity of heart failure, is the first
decision-step for further treatment procedures. In case
of severe decline of health an emergency transport to
the hospital is implemented. If no emergency transport to
the hospital is necessary there are several possibilities for
patient treatment in this simulation block of the model.
One sub-process could be the change of medication of the
patient. In that case no personal contact to any health care
provider is necessary. Alternatively there are three possible
health care services: the doctor, the specialist, or the
ambulance. If an improvement in the state of health takes
place no further events are necessary and the patient is
forwarded to the beginning of the simulation block. If no
improvement is obtained, patients can die via implemented
mortality rates, or the patients get hospitalized via emer-
gency or normal transport, and therefore are transferred to
the inpatient care procedure, represented by block 2.Outpatient care – procedure of telemedical treatment
The course of the telemedical treatment is based on the
most common applications of telemonitoring systems for
heart failure patients. The patient is consistently super-
vised through the telemonitoring system and has to send
physiological data such as weight, blood pressure, heart
rate and medication once a day to the telemedicine centre
[14,17-19]. In case of worsening of the health status the
Figure 2 Flowchart of the implemented treatment procedure for inpatient care of heart failure patients.
Schroettner and Lassnig Health Economics Review Page 4 of 112013, 3:26
http://www.healtheconomicsreview.com/content/3/1/26authorized physician is notified. If no emergency occurs,
the physician is able to induce appropriate measures.
The course of the telemedical treatment can be seen in
Figure 4.
In the model the control cycle takes place on a weekly
basis. Potentially dangerous changes in the health status
of a patient could lead to an event of emergency, which
results in a hospitalization of the patient (transfer to theinpatient care, represented by block 2). If vital parameters
can be improved, for example via new medication or an
adaption of the current treatment, an intervention event is
executed in the model. If no intervention is chosen the
model offers the possibility of a home visit of the doctor, a
visit to the doctor or a hospitalization of the patient. After
the face to face contact another decision, whether the
treatment can be adapted to improve the patient’s health
Figure 3 Flowchart of the implemented conventional treatment procedure for outpatient care of heart failure patients.
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in the simulation model. Finally, if no improvement of
the patient’s physiological parameters can be achieved,
hospitalization is possible or mortality rates are imple-
mented in the model to consider possible death scenarios.After this process the patient can undergo a change in his
NYHA class, depending on improvement or worsening
of his health status. In both cases, the conventional and
the telemedical care, extramural mortalities have been
implemented separately for each NYHA class.
Figure 4 Flowchart of the implemented telemedical treatment procedure for outpatient care of heart failure patients.
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For economic analyses of the course of treatment of
each patient, outpatient as well as inpatient care costs
are considered in the simulation model. Since a decrease
in hospitalizations is expected when patients are equipped
with a telemonitoring system and the inpatient care
accounts for the vast majority of the total costs for
heart failure treatment, it is very important to implement
these expense factors as properly as possible. Therefore
the calculation in this model is based on the Austrian
diagnosis-related-groups (DRG) system. In the DRG
model, hospital stays are grouped into procedure-orienteddiagnosis-related case flat rates (LDF is the German
abbreviation of “Leistungsorientierte Diagnosenfallgruppe”,
which can be translated as “procedure-oriented diagnosis-
related case group”). Every case flat rate has a typical length
of stay (defined by a concrete minimum and maximum)
allocated to it, during which a specific point score is
reimbursed to the hospital. For the diagnosis of heart
failure the minimum and maximum are currently defined
as 4 and 12 days. If the length of stay exceeds beyond the
maximum, supplementary points are added to the case flat
rate for each additional day. In contrast, if a hospital stay
is shorter than the minimum length of stay, a reduced flat
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and degrees of severity are taken into account in different
LDF-groups. Therefore LDF points and length of stay
in the simulation model can be varied for each NYHA
group. In addition to these costs resulting from standard
hospital treatment expenses from intensive care units are
considered in the model. Stays at intensive care units are
reimbursed by a daily supplementary score in addition
to the normal case flat rate and can be regarded as an
indicator of severity for heart failure. Following this the
implemented LDF rate and the length of stay at intensive
care units are variable for each NYHA group and result in
an additional cost contribution of inpatient care. If an
individual medical procedure (e.g. expensive surgery) is
necessary, a procedure component will be considered in
the model and additionally increases the total expenses
of inpatient care. An illustration of the overall cost
composition including inpatient and the outpatient care
costs is shown in Figure 5.
Outpatient care costs are divided into costs for the
standard care process and expenses for the telemedical
system, if applicable. Standard care costs comprise
expenditures of visits to the general practitioner or a
specialist, home visits or a medical examination in an
ambulance.
For the telemedical treatment of patients different
adaptable variants of financing the telemedical system
are implemented in the model. One opportunity is to
consider a fixed monthly rate per patient, including a
lending fee for the equipment and costs for the main-
tenance of the system. Another possibility is to split up
equipment costs and costs for the service of the system.
In this case a separate amount for the acquisition of
the telemonitoring equipment will be considered, as
well as monthly overheads for the general use of the
system and maintenance. In both financing concepts
additional expenses for the physician’s efforts of moni-
toring the patients are considered in the model. All ofFigure 5 Illustration of the composition of the overall costs divided in
alternative financing.the described parameters can be individually entered
for various simulations and summarized to the total costs
of outpatient care.
Results
The result of this work is the development of a stochastic
simulation model, which allows to compare health and
cost outcomes of different integrated care concepts for
the treatment of heart failure patients. Additionally to
the simulation of standard outpatient and inpatient care
procedures in Austria the approach of a telemedical moni-
toring system for heart failure patients was implemented
in this economic model. Model parameters can be directly
modified via input masks on the simulation screen to
set, for example, mortality rates, hospitalizations, costs for
visits to the ambulance, amount and type of individual
medical procedures and class changes to conduct specific
simulation runs. In total 3 input masks allow the adjust-
ment of the event-probabilities, which then influence
the patient’s treatment procedure, but do not interfere
with the general model structure. As a first step for each
simulation the amount and the distribution of patients
under investigation can be adjusted for each NYHA class.
In a second step the probabilities for events occurring
in the outpatient and inpatient care can be specified.
This refers to the parameters previously described in
the methods section, for example the distribution of home
visits, doctor and specialist visits, in-hospital length of
stay, mortality, intensive care unit treatment and so on.
Finally the model allows the separate adjustment of
expenses for standard care events, telemedical procedure
and hospitalization as described above (see Figure 5).
In addition the amount of Euros per procedure-oriented
diagnosis-related case group point is adjustable for pos-
sible future adaptations.
The time horizon for running the simulation is variable
and can be chosen by the user. One time-step in the
model environment is equivalent to one day in the realto inpatient and the outpatient care costs including
Table 2 cost parameters for the inpatient and
outpatient care
Health care resource Costs
Visit to the general practitioner 25 €
Visit to the specialist 31 €
In-hospital stay 1523 €[15]
Intensive care stay 2496 €[15]
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over a longer time span as in most of the conducted
studies (follow-up between 6 and 12 months) it is possible
to determine the breakeven point for different concepts
of care. This point changes noticeably by twisting one
of the many screws given in the model such as the
hospitalization rate, the length of stay, the overall
NYHA distribution of patients, telemedical treatment
costs or the probabilities for NYHA class change.
Each simulation produces a set of graphs and tables
describing the incurrence and constitution of the overall
treatment expenses for the virtual heart failure patients.
Additionally the development of the patient collective
for each NYHA class and its course through the model
structure can be observed over time. Moreover the
developed model offers the chance to estimate the most
important influence parameters and their impacts on
different treatment processes by using sensitivity analysis.
To outline some of the potential model results, a
comprehensive scenario in regard to overall outcomes of
telemedical and conventional care has been simulated.
Intramural NYHA class changes, in-hospital mortality
rates as well as different concepts for the calculation of
costs for the telemedical system have been used.
Tables 1 and 2 show a summary of input parameters
and treatment costs for the simulated scenarios. Visits to
the ambulance, costs of medication, costs for transport
and extramural mortalities have not been included in
these scenarios.
The simulations are based on a starting pool of 100
patients over the time span of three years, with the fol-
lowing NYHA distribution: 0% NYHA 1, 61% NYHA 2,
37% NYHA 3 and 2% NYHA4 [8]. The final outcomes
are obtained by taking the mean of 10 individual simula-
tion runs to reduce randomness of the stochastic model.
On one side, the expenses for the telemedical system were
implemented as a monthly fixed rate of 100 € per patientTable 1 summary of the input parameters for the
simulated scenarios
Parameter Conventional Telemedical
care care
Median length of stay 10 days [17] 6.5 days [17]
Median length of stay 2 days 2 days
(Intensive unit)
Hospitalizations 32.08%a[17] 20.37%a[17]
Visits to general practitioner 1.42b[20] 2.84b[20]
Visits to specialist 0.3b[20] 0.46b[20]
Intensive care treatment 12.6%c 12.6%c
In-hospital mortality 7.1%c 7.1%c
a… probability for the time period of half a year.
b… amount of visits for half a year.
c… probability per stay.(TM_scenA) and on the other one acquisition costs for
the telemonitoring equipment were taken into account
with 1000 € for each system, monthly overheads for the
use and maintenance of the system with 500 € and costs
for the physician’s additional efforts with 40 € for each
patient per month (TM_scenB).
In Figure 6 the results of the overall costs are compared.
The telemedical scenarios A and B are matched with
the conventional care process, which was set to 100%.
The telemedical treatment is not cost efficient after the
first year. Depending on the method of funding for the
telemedical system the overall costs exceed the expenses
for the conventional care up to 20%. Under the given
simulation parameters the break-even point for both
telemedical calculations lies approximately at two years
and cost savings of up to 8% can be achieved within
the first three years by using a telemedical treatment
approach. Regarding health outcomes it could be assessed
that 14 patients treated via conventional care died during
the time period of three years in comparison to seven who
received telemedical treatment.
Discussion
Simulation model
There are different decision-analytic modelling approaches
to estimate the cost effectiveness of health technologies
for chronic heart failure described in the literature.
Goehler et al. identified 34 modelling studies investigating
different interventions [21]. Most of them used Markov
models (27) and a few used mathematical equation sets
(4) or discrete event simulation (3) models. In principle
there is no general recipe which modelling approach
should be chosen, however discrete event simulation
models (DES) have some essential advantages [22-24].
One of these characteristics of DES models is the ability to
express the experience of individuals over time in terms of
events and their consequences rather than reflecting the
world as a series of states used in Markov simulations
[23]. It seems to be well understandable to model the
reality in terms of events that can happen over the course
of health care procedures. DES methods are more efficient
in using attributes, in our case the NYHA classification
of the virtual patients. On the one hand changes of the
severity of the disease can be considered and thus
influence following treatment procedures and on the
Figure 6 Bar diagram of the overall costs for the simulation of conventional and telemedical care over a time span of 3 years.
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assess the distribution of NYHA classes at follow-up
time, not only as usual at baseline. Relating to the
target group of HF patients, using NYHA classification
as an assessment tool for disease progression is a common
approach in decision analytic models. Apart from the
modelling approach previously published models mainly
investigate pharmacological treatment versus standard
therapy of heart failure patients. For example Caro et al.
developed discrete event simulations to compare the
course of HF patients after the implantation of an ICD
(implantable cardioverter defibrillator) with additional
amiodarone medication [25,26]. A linear model based
on an Excel platform from Klersy et al. investigates the
economic impact of patient remote monitoring compared
to usual care. The model is very simply structured and
only considers costs for hospitalizations [12]. However,
so far no comprehensive decision analytic model was
found in literature, which was developed to compare the
incurred costs of conventional medical care and different
integrated care approaches (outpatient and inpatient
courses) including a telemedical monitoring system of
heart failure patients. This is in marked contrast to the
high number of different studies regarding economy
impact, cost predictions, or cost-effectiveness on these
possible treatment concepts. Müller et al. in 2010 sum-
marized experiences from different telemedical supportprojects in Germany. It was concluded that chronic heart
failure patients benefit from telemedical monitoring with
transfer of vital parameters [18]. But it is still an open
question which patient with regard to NYHA classification
benefits most from the telemedical care system. For future
cost savings and/or reimbursement strategies this will
be one of the most important questions which have to
be clarified. First experiences with simulation models
showed that the cost effectiveness of telemedical treat-
ment strongly depends on the collective of patients
(amount, NYHA class) [27,28]. Therefore an extension
of the simulation model by using attributes for NYHA
classification and tracking the virtual patients was
unavoidable [29].Cost estimation
For the first time a comprehensive simulation model
regarding cost estimations for HF patient treatment,
including outpatient as well as inpatient care was devel-
oped. Compared to other existing models which primarily
consider hospitalization cost factors, the total cost
estimation is implemented in a more exact approach.
Additionally the developed model takes costs of out-
patient care, costs for monitoring the patients and
equipment costs into account. In other studies regarding
economic analyses of HF telemonitoring systems these
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in one comprehensive work. In his review Seto concluded
that most of the studies included hospitalization costs
and telemonitoring equipment costs, but only one
study discussed the direct impact of HF telemonitoring
on expenses for the patient [11]. A consideration of the
so called indirect costs for the patients, currently not
implemented, seems to be an improvement of the
presented model. For example travel costs for visits to
physician or to ambulatory as well as reductions in
income play an important role for each individual.
Additionally the decrease in number of home vistits seems
to be a potential area of cost savings. The modular con-
cept of the developed model enables the consideration
of indirect costs. Further the model structure allows
the separate analysis of all implemented cost contribu-
tions. Medication costs have not been considered so far
and should be implemented in the next extension step
of the simulation model. However, increasing model
complexity will negatively influence the traceability
and comprehension of the existing model. Therefore a
balance between exact reproductions of real processes
and their cost contributions and traceability of the
model has to be kept in mind for future extensions.
Compared to existing models and estimations for cost
savings regarding telemedical care, the often overlooked
implementation costs for the telemonitoring system have
been considered in the developed model. In addition
different adaptable variants of financing the telemedical
system are taken into account. Regional disparities (age
distribution, population, etc.) are another deciding factor,
which can account for the difference between potential
success or failure of telemedical systems. Depending on
the quality and existence of data the model can be used to
map the present method of care in for example a city or a
state and to compare it with alternative treatment pro-
cesses for heart failure patients.
Considering all contributions the model allows the
simulation of various concepts of reimbursement modal-
ities, such as tariffs for ambulatory patient control, per
capita monthly rates for a service contract or device
based reimbursement. The systematic search from Seto
also found articles, where co-payments by the patients
would be accepted to access telemedicine service instead
of travelling to the physician [11]. Simulation results
received from such different concepts can support
third-party payers when defining reimbursement strategies.
Another application for the developed model is budget
impact analyses, where hypothetical cohorts of patients
can be observed over a defined simulation time. The
economic analyses from Klersy et al. pointed out that
the limited follow-up time of most existing studies [12]
has an important influence. As mentioned above the time
horizon for running simulations is variable, accordingly thefollow-up time can be extended by using the developed
simulation model.
The results of the simulated scenarios illustrate the
financial outcomes for both methods of care, with
different approaches to the calculation of the overall
costs for the telemedical system. It can be seen that
under the given simulation conditions the telemedical
care has a potential for cost savings after the first two
years, which increases noticeably depending on the
variant of funding. The choice of the distribution of
NYHA patients strongly affects the overall costs for
both methods of care. With further simulations and
analyses of the model, different results can be discussed,
whereby the effectiveness of the telemedical treatment
of heart failure patients is in the centre of attention.
Under the given simulation parameters a reduction of
deaths could be achieved, however it has to be mentioned
that this is based on in-hospital mortality only.
With the developed model different scenarios can be
simulated and analysed to develop sustainable health
care solutions. As previously described the model is
based on many different probabilities which strongly
influence the simulation results. Therefore it has to be
considered that NYHA-related data is specific to the
target study group and the choice of data used for the
model should be made carefully. Depending on the
quality of implemented data (e.g. NYHA related transition
probabilities, mortality rates, etc.) valuable predictions
for future developments can be achieved, representing
real life scenarios with good precision.
Conclusions
The developed model represents a comprehensive tool,
which opens up a wide field of possible simulation scenar-
ios for the treatment of heart failure patients with special
focus on overall cost estimations and reimbursement
strategies. The simulated scenarios show that telemedical
care has the potential of cost savings. However, it has to
be stated that these are preliminary results. With the
amount of adjustable parameters it is possible to simulate
a variety of scenarios to clarify under which condition a
telemedical provision for heart failure patients leads
to improved health outcomes and economic benefits.
Based on the developed model, prospective planned
cost reduction activities, such as the possible imple-
mentation of telemedical care can be assessed and used
for decision making in health care systems.
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